Logos Global Management’s Design Therapeutics DSGN Stock Holding History

Logos Global Management’s Portfolio DSGN Stock Details DSGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.4M	Buy	3,000,000 +1,050,000	+54%	+$13.1M	1.87%	17
2026 Q1	$20.7M	Sell	1,950,000 -550,000	-22%	-$5.57M	1.04%	32
2025 Q4	$23.4M	Sell	2,500,000 -1,155,000	-32%	-$9.04M	1.42%	25
2025 Q3	$27.5M	Sell	3,655,000 -562,627	-13%	-$2.82M	2.47%	16
2025 Q2	$14.2M	Hold	4,217,627	–	–	1.57%	22
2025 Q1	$16.3M	Hold	4,217,627	–	–	2.89%	15
2024 Q4	$26M	Hold	4,217,627	–	–	3.04%	12
2024 Q3	$22.7M	Sell	4,217,627 -814,874	-16%	-$3.83M	2.45%	17
2024 Q2	$16.9M	Hold	5,032,501	–	–	1.36%	20
2024 Q1	$20.3M	Hold	5,032,501	–	–	1.64%	20
2023 Q4	$13.3M	Hold	5,032,501	–	–	1.24%	21
2023 Q3	$11.9M	Buy	5,032,501 +2,235,000	+80%	+$10.4M	1.58%	24
2023 Q2	$17.6M	Hold	2,797,501	–	–	2.4%	15
2023 Q1	$16.1M	Hold	2,797,501	–	–	2.31%	15
2022 Q4	$28.7M	Hold	2,797,501	–	–	3.36%	11
2022 Q3	$46.8M	Hold	2,797,501	–	–	5.75%	5
2022 Q2	$39.2M	Hold	2,797,501	–	–	7.19%	4
2022 Q1	$45.2M	Buy	2,797,501 +25,000	+0.9%	+$383K	5.86%	4
2021 Q4	$59.4M	Hold	2,772,501	–	–	6.12%	3
2021 Q3	$40.7M	Buy	2,772,501 +40,000	+1%	+$665K	2.94%	12
2021 Q2	$54.3M	Hold	2,732,501	–	–	4.57%	3
2021 Q1	$81.7M	Buy	+2,732,501	New	+$92.2M	7.97%	3

Other funds holding DSGN

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Logos Global Management's DSGN Position: Q2 2026 in Review

Logos Global Management increased its Design Therapeutics (DSGN) stake by 54% in Q2 2026, buying an estimated $13.1M and bringing the position to 3,000,000 shares worth $43.4M. The position accounts for 1.87% of the portfolio, ranked #17.

Logos Global Management first reported a position in DSGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $81.7M in Q1 2021. 137 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

Logos Global Management held 3,000,000 shares of Design Therapeutics worth $43.4M as of Q2 2026.
Logos Global Management bought 1,050,000 Design Therapeutics shares in Q2 2026, an estimated $13.1M.
Design Therapeutics made up 1.87% of Logos Global Management's portfolio in Q2 2026, its #17 holding.
Logos Global Management first reported a position in Design Therapeutics in Q1 2021 and has held it in 22 quarters since.
Logos Global Management's Design Therapeutics position peaked at $81.7M in Q1 2021.
137 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.